Christopher Heberlig

Christopher Heberlig

Director of Finance/CFO at KSQ Therapeutics, Inc.

49 year
Health Technology
Consumer Services
Commercial Services

Profile

Christopher Heberlig was the founder of Kiniksa Pharmaceuticals Ltd.
(founded in 2015) where he held the title of Chief Financial Officer & Executive Vice President.
He is currently the Chief Financial Officer at KSQ Therapeutics, Inc. Mr. Heberlig's former positions include Finance Director & Controller at Panacos Pharmaceuticals, Inc., Principal at EPIX Pharmaceuticals, Inc. and NetGenesis Corp., and Principal at PricewaterhouseCoopers LLP.
He was also the President & Chief Financial Officer at Organovo Holdings, Inc. from 2020 to 2021.
Mr. Heberlig received his undergraduate degree from St. Lawrence University and his MBA from Questrom School of Business.

Christopher Heberlig active positions

CompaniesPositionStart
Director of Finance/CFO -
All active positions of Christopher Heberlig

Former positions of Christopher Heberlig

CompaniesPositionEnd
ORGANOVO HOLDINGS, INC. Director of Finance/CFO 2021-05-06
KINIKSA PHARMACEUTICALS, LTD. Founder 2020-03-19
SYNAGEVA BIOPHARMA CORP Corporate Officer/Principal 2014-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Christopher Heberlig's experience

Training of Christopher Heberlig

St. Lawrence University Undergraduate Degree
Questrom School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Heberlig's experience

Connections

65

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
PANACOS PHARMACEUTICALS, INC.

Health Technology

KINIKSA PHARMACEUTICALS, LTD.

Health Technology

ORGANOVO HOLDINGS, INC.

Health Technology

Private companies5

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Heberlig